Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?

Autor: Cerna K; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic.; GENNET, Prague, Czech Republic., Duricova D; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic.; Institute of Pharmacology, First Faculty of Medicine, Charles University, Prague, Czech Republic., Lukas M; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic.; Institute of Animal Physiology and Genetics, Czech Academy of Sciences, Libechov, Czech Republic.; Department of Surgery, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic., Kolar M; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic.; Institute of Animal Physiology and Genetics, Czech Academy of Sciences, Libechov, Czech Republic., Machkova N; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic., Hruba V; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic., Mitrova K; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic.; Department of Pediatrics, University Hospital Motol and Second Faculty of Medicine, Charles University, Prague, Czech Republic., Kubickova K; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic., Kostrejova M; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic.; Department of Internal Medicine, Hospital of the Sisters of Mercy of St. Charles Borromeo, Prague, Czech Republic., Jirsa J; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic., Kastylova K; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic., Peterka S; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic.; Department of Internal Medicine, Hospital Jindrichuv Hradec, Jindrichuv Hradec, Czech Republic., Vojtechova G; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic.; ResTrial GastroEndo, Prague, Czech Republic., Lukas M; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic.

Publikováno v: Crohn's & colitis 360 [Crohns Colitis 360] 2023 Jul 25; Vol. 5 (4), pp. otad040. Date of Electronic Publication: 2023 Jul 25 (Print Publication: 2023).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Switching from Intravenous to Subcutaneous Biological Therapy for Inflammatory Bowel Disease Patients Remains a Challenge.

Autor: Richter, Vered^1,2 (AUTHOR) docdannycohen@yahoo.com, Cohen, Daniel L.¹ (AUTHOR) danazelnik@gmail.com, Kriger-Sharabi, Ofra³ (AUTHOR) ofranirsh@gmail.com, Zelnik Yovel, Dana^1,2 (AUTHOR) kochenadav@gmail.com, Kochen, Nadav¹ (AUTHOR) haim_shirin@yahoo.com, Broide, Efrat^2,4 (AUTHOR), Shirin, Haim^1,2 (AUTHOR)

Publikováno v: Journal of Clinical Medicine. Mar2024, Vol. 13 Issue 5, p1357. 11p.

COVID-19 Vaccination in Inflammatory Bowel Disease (IBD).

Autor: Kubas, Aleksandra¹ (AUTHOR) aleksandra.kubas@stud.umed.lodz.pl, Malecka-Wojciesko, Ewa¹ (AUTHOR) ewa.malecka-panas@umed.lodz.pl

Publikováno v: Journal of Clinical Medicine. May2022, Vol. 11 Issue 9, p2676-2676. 12p.

COVID-19 Vaccines for Adults and Children with Autoimmune Gut or Liver Disease.

Autor: Peshevska-Sekulovska, Monika, Bakalova, Plamena, Snegarova, Violeta, Lazova, Snezhina, Velikova, Tsvetelina

Publikováno v: Vaccines; Dec2022, Vol. 10 Issue 12, p2075, 16p